OTC Link · Healthcare · Drug Manufacturers - Specialty & Generic
CRESCO LABS INC
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-06 | Q2 2026 | -0.02 | 0.04 | +300.00% | $173.3M | ✅ Beat | — | — | — |
| 2026-05-08 | Q1 2026 | -0.03 | -0.03 | +0.00% | $151.0M | ➖ Inline | — | — | — |
| 2026-03-05 |
| Q4 2025 |
| -0.02 |
| 0.01 |
| +150.00% |
| $161.6M |
| ✅ Beat |
| — |
| — |
| — |
| 2025-11-05 | Q3 2025 | -0.03 | -0.06 | -100.00% | $164.9M | ❌ Miss | — | — | — |
| 2025-03-12 | Q4 2024 | -0.01 | -0.01 | +0.00% | $175.9M | ➖ Inline | -6.04% | -4.03% | -19.46% |
| 2024-11-08 | Q3 2024 | 0.01 | -0.03 | -400.00% | $179.8M | ❌ Miss | — | — | — |
| 2024-05-15 | Q1 2024 | -0.02 | -0.02 | +0.00% | $184.3M | ➖ Inline | +6.22% | -2.87% | -22.49% |
| 2024-03-13 | Q4 2023 | -0.02 | 0.01 | +150.00% | $188.2M | ✅ Beat | — | — | — |
Showing last 8 quarters.